Comparison of Glucose Lowering Efficacy of Human GLP-1 Agonist in Taiwan Type 2 Diabetes Patients after Switching from DPP-4 Inhibitor Use or Non-Use.

Tsai, Chia-Jen; Tsao, Cheng-Feng

Tsai, Chia-Jen; Tsao, Cheng-Feng.

Afiliación

Tsai CJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, College of Medicine, Kaohsiung 833, Taiwan.
Tsao CF; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University, College of Medicine, Kaohsiung 833, Taiwan.

J Pers Med ; 12(11)2022 Nov 16.

Article en En | MEDLINE | ID: mdl-36422091

Palabras clave

DPP-4 inhibitor; GLP-1 agonist; Taiwan; type 2 diabetes mellitus

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Idioma: En Revista: J Pers Med Año: 2022 Tipo del documento: Article País de afiliación: Taiwán Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google